Friday, June 19, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 912 of 1,261
  1. US 8236983

    Composition and method for the treatment of diseases affected by apoptosis

    The Board of Regents of the University of Texas System · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  2. US 8236279

    Bisaminoethanethiol-targeting ligand conjugates and compositions

    The Board of Regents of the University of Texas System · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  3. US 8236835

    Heterocyclic inhibitors of stearoyl-CoA desaturase

    Xenon Pharmaceuticals Inc. · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  4. US 8236797

    Bromo-phenyl substituted thiazolyl dihydropyrimidines

    SUNSHINE LAKE PHARMA CO., LTD. · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  5. US 8236839

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  6. US 8236846

    Dual-acting antihypertensive agents

    Theravance, Inc. · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  7. US 8236960

    Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy) phenylmethyl)carbamide and its tartrate salt and crystalline forms

    ACADIA Pharmaceuticals Inc. · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  8. US 8236925

    Protein nanorings

    Regents of the University of Minnesota · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  9. US 8236987

    Selective estrogen receptor modulator compositions and methods for treatment of disease

    The Regents of the University of California · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  10. US 8236837

    Tricyclic compound and pharmaceutical use thereof

    Takeda Pharmaceutical Company Limited · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  11. US 8236829

    Bicyclic derivatives as modulators of voltage gated ION channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  12. US 8236815

    Ion channel modulators and methods of uses

    Vertex Pharmaceuticals Incorporated · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  13. US 8236784

    Composition comprising threitol phosphate and salts thereof

    Sunny BioDiscovery · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  14. US 8236780

    Galactose—pronged polysaccharides in a formulation for antifibrotic therapies

    GALECTIN THERAPEUTICS, INC. · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  15. US 8236777

    MicroRNA (miRNA) and downstream targets for diagnostic and therapeutic purposes

    Julius-Maximilians-Universitat Wurzburg · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  16. US 8236754

    Methods for improving the structure and function of arterioles

    The Regents of the University of California · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  17. US 8236522

    Bacterial extract for digestive or urinary tract disorders and process for its preparation

    OM PHARMA · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  18. US 8236350

    Polymer for tissue engineering applications and drug delivery

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  19. US 8236833

    Biphenyl derivatives as modulators of voltage gated ion channels

    Vertex Pharmaceuticals Incorporated · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  20. US 8236313

    Prevention of tissue ischemia, related methods and compositions

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Aug 7, 2012 · Expires Aug 2, 2032

    granted
  21. US 8232448

    Transgenic mouse with a homozygous mutation in the CMAH gene

    The Regents of the University of California · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted
  22. US 8232379

    Nucleic acids encoding chimeric flavivirus immunogens comprising the Japanese encephalitis virus (JEV) prM signal sequence

    The United States of America as represented by the Secretary of the Department of Health and Human Services, Centers for Disease Control and Prevention · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted
  23. US 8232302

    Thiazoles and oxazoles useful as modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted
  24. US 8232373

    Immunogenic peptide composition for the prevention and treatment of alzheimer's disease

    United Biomedical, Inc. · Granted Jul 31, 2012 · Expires Jul 26, 2032

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.